Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.
about
The Landscape of Pancreatic Cancer Therapeutic Resistance MechanismsSingle cell resolution in vivo imaging of DNA damage following PARP inhibitionPoly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.Poly(ADP-ribosyl)ation of p53 contributes to TPEN-induced neuronal apoptosis.SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activationInitial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatmentIs there an epigenetic component underlying the resistance of triple-negative breast cancers to parp inhibitors?The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.Association of γH2AX at Diagnosis with Chemotherapy Outcome in Patients with Breast Cancer.Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.Hydrogen peroxide induces adaptive response and differential gene expression in human embryo lung fibroblast cells.Putting the brakes on p53-driven apoptosis.Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
P2860
Q26765247-6DF217B0-6D49-4F6F-B461-71E0B98262DDQ30650918-36B305CE-2FA8-4044-A2AF-10133BFE7F26Q34982593-BADD0B94-A5DC-4ED4-B255-73DB82219471Q35450753-331945B9-5C26-42C9-A2EB-EDFC3848C1A5Q35531218-8CC12EE4-A313-4CF5-ABF6-BF6078044E05Q35684995-05F546A8-A718-4830-B454-3114A7FEEB70Q36280791-35D88AA0-464F-4512-80EE-7DFC01DF8BADQ36392155-A92CDD24-B325-4D1B-9677-5C7579097E15Q36490203-3040FC76-0E4D-4821-8955-F603E6DF3A59Q37372483-8F9016C3-0A8E-4B17-8B0B-E128702E180AQ37738231-FC558DCA-6EAF-4373-B851-C073277FC3D8Q38740969-E7437001-7E32-4A09-9E3D-7935DE81474FQ39367075-1945DB3A-6749-4625-8552-A41D8B4759B6Q42414248-AC9977FD-CC8E-47EE-BFA2-5915E38D3A62Q42739081-B2C67BAF-52FD-4B95-B429-57C39492F3FFQ42826404-16105874-3305-4ADA-823C-DAB3CF9ACD02
P2860
Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Poly(ADP-ribose) polymerase in ...... induced by DNA damaging agent.
@ast
Poly(ADP-ribose) polymerase in ...... induced by DNA damaging agent.
@en
type
label
Poly(ADP-ribose) polymerase in ...... induced by DNA damaging agent.
@ast
Poly(ADP-ribose) polymerase in ...... induced by DNA damaging agent.
@en
prefLabel
Poly(ADP-ribose) polymerase in ...... induced by DNA damaging agent.
@ast
Poly(ADP-ribose) polymerase in ...... induced by DNA damaging agent.
@en
P2093
P2860
P356
P1433
P1476
Poly(ADP-ribose) polymerase in ...... induced by DNA damaging agent.
@en
P2093
Alice P Chen
Diana Nguyen
Donna Voeller
James H Doroshow
Joseph E Tomaszewski
Larry Rubinstein
Maria Zajac-Kaye
Sherry X Yang
Shivaani Kummar
P2860
P304
P356
10.4161/CC.10.23.18170
P50
P577
2011-12-01T00:00:00Z